ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailMenu BurgerPositive ArrowIcon PrintIcon SearchSite TitleTitle ChevronIcon Twitter
Health Technology

Nipro Corp.

Business Summary

Nipro Corp. engages in the manufacture and sale of medical equipment, pharmaceutical products, and glass products. Its operations are carried out through the following segments: Medical related, Pharmaceutical related, Pharma Packaging, and Others. The Medical related segment provides injection and infusion-related products, artificial organ-related products, functional products, and dialysis and diabetes-related products. The Pharmaceutical related segment involves the manufacture and sale of injections, oral agents, and pharmaceutical kit products. The Pharma Packaging segment provides glass products for bottle tubes, ampoules, thermos-use, and lighting. The Others segment includes real estate leasing. The company was founded on July 8, 1954 and is headquartered in Osaka, Japan.

Financial Highlights

Mar 2019 JPYUSD
Revenue426,399M3,845.08M
Gross Profit132,042M1,190.69M
Operating income23,828M214.87M
Income before tax21,233M191.46M
Net income12,136M109.43M
EBITDA62,452M563.16M
Diluted EPS66.740.60
Dividends Per Share280.25
Total Assets849,273M7,672.88M
Total liabilities677,438M6,120.41M
Total equity161,489M1,458.99M
Operating cash flow41,362M372.98M
Currency in JPYCurrency in USD

Historical Data

 Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Revenue 325,084M 366,650M 359,699M 395,397M 426,399M
Gross Profit 99,559M 115,877M 115,097M 128,791M 132,042M
Operating income 16,571M 25,083M 28,801M 26,997M 23,828M
Income before tax 19,908M 26,284M 18,324M 17,026M 21,233M
Net income 12,470M 19,718M 11,346M 11,830M 12,136M
EBITDA 49,632M 58,918M 62,836M 62,993M 62,452M
Diluted EPS 80.95 114.67 61.33 64.50 66.74
Dividends Per Share 32.50 33.50 29 28.50 28
Total Assets 698,577M 710,681M 754,748M 828,722M 849,273M
Total liabilities 519,767M 535,174M 578,335M 645,233M 677,438M
Total equity 167,660M 165,998M 166,083M 172,622M 161,489M
Operating cash flow 27,981M 29,934M 33,472M 41,046M 41,362M
 Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Revenue 2,959.16M 3,053.27M 3,321.70M 3,567.52M 3,845.08M
Gross Profit 906.26M 964.96M 1,062.88M 1,162.03M 1,190.69M
Operating income 150.84M 208.87M 265.96M 243.58M 214.87M
Income before tax 181.21M 218.87M 169.21M 153.61M 191.46M
Net income 113.51M 164.20M 104.77M 106.73M 109.43M
EBITDA 451.78M 490.63M 580.27M 568.36M 563.16M
Diluted EPS 0.73 0.95 0.56 0.58 0.60
Dividends Per Share 0.29 0.27 0.26 0.25 0.25
Total Assets 5,825.11M 6,323.06M 6,773.29M 7,792.40M 7,672.88M
Total liabilities 4,334.10M 4,761.54M 5,190.11M 6,067.06M 6,120.41M
Total equity 1,398.04M 1,476.91M 1,490.46M 1,623.14M 1,458.99M
Operating cash flow 254.70M 249.27M 309.10M 370.34M 372.98M

Valuation Measures

Mar 2019
PER19.39
ROA1.44%
ROE7.26%
Operating margin5.58%
Profit margin2.84%

Key executives

  • President & Representative Director: Yoshihiko Sano
  • Director & Manager-Administration: Masanobu Iwasa
  • Director & Deputy Manager-Production Business: Hideo Okamoto
  • Director: Itsuo Akasaki
  • Director & Manager-Production Technology Center: Kazuhiko Sano

Shareholders

  • Nippon Electric Glass Co., Ltd. (11.7%)
  • Nipro Corp. (4.8%)
  • Nomura Asset Management Co., Ltd. (3.0%)
  • Asset Management One Co., Ltd. (2.6%)
  • Resona Holdings, Inc. (2.5%)
  • The Vanguard Group, Inc. (1.8%)
  • JAPAN POST INSURANCE Co., Ltd. (1.3%)
  • Norges Bank Investment Management (1.2%)
  • Dimensional Fund Advisors LP (1.1%)
  • SANO KAZUMI (1.1%)

Contact Details

  • Website:http://www.nipro.co.jp
  • Address: 3-9-3 Honjo-Nishi, Kita-Ku, Osaka, 531-8510, Japan
  • Phone: +81.6.6372.2331

Related Companies

  • Nipro PharmaPackaging France SAS
  • Nipro ES Pharma KK
  • Nipro Medical OOO
  • Anyang Nipro Changda Pharmaceutical Packaging Co. Ltd.
  • OOO Ural Glass Plant
  • Nipro Nordics AB
  • Nipro India Corp. Pvt Ltd.
  • Nipro Medical (India) Pvt Ltd.
  • Nipro JMI Co. Ltd.
  • Nipro Poland Sp zoo
  • Nipro Glass Germany AG
  • Nipro Middle East Free Zone Establishment
  • Nipro Malaysia Sdn. Bhd.
  • Nipro France SA
  • Jilin Nipro Jiaheng Pharmaceutical Packaging Co. Ltd.
  • Nipro Medical Corporation Produtos Medicos Ltda.
  • Nipro Sales (Thailand) Co. Ltd.
  • Nipro Medical of Puerto Rico, Inc.
  • Nipro Trading (Shanghai) Co. Ltd.
  • Nipro South Africa Pty Ltd.
  • Nipro Asia Pte Ltd.
  • PT Nipro Indonesia Jaya
  • Nipro Medical (Hefei) Co. Ltd.
  • Nipro Glass Americas Corp.
  • Nipro Glass India Pvt Ltd.
  • Nipro Senegal SUARL
  • Nipro Pharma Glass AG
  • Unitika Ltd. /Medical Products Business/
  • Nipro (Shanghai) Co. Ltd.
  • Cell Science & Technology Institute, Inc.

Competitors

  • Takeda Pharmaceutical Co. Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • Treet Corporation Limited
  • Bioteque Corporation
  • Gerresheimer AG
  • Nephros, Inc.
Last Updated on 6 Dec, 2019

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Get Unlimited access

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends October 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media